Price T Rowe Associates Inc Solid Biosciences Inc. Transaction History

Price T Rowe Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.46 $6.91 Million - $10.1 Million	-4,088,350 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.38 - $3.77 $23,409 - $37,081	-9,836 Reduced 0.24%	4,088,350 $9.77 Million
Q2 2021 Aug 16, 2021	SELL	$3.49 - $5.51 $386,754 - $610,607	-110,818 Reduced 2.63%	4,098,186 $15 Million
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $22.6 Million - $45.1 Million	4,209,004 New	4,209,004 $23.3 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $30.6M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.